These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 7620273

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.
    Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Rosenfeld R, Tauber JP.
    Diabetes Metab; 1996 Jul; 22(4):245-50. PubMed ID: 8767170
    [Abstract] [Full Text] [Related]

  • 3. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 4. [The role of growth hormone in the development of complications in insulin-dependent diabetes].
    Krawczuk-Rybak M, Urban M.
    Padiatr Grenzgeb; 1991 Apr; 30(3):237-43. PubMed ID: 2067873
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone (GH) hypersecretion and GH receptor resistance in streptozotocin diabetic mice in response to a GH secretagogue.
    Johansen PB, Segev Y, Landau D, Phillip M, Flyvbjerg A.
    Exp Diabesity Res; 2003 Apr; 4(2):73-81. PubMed ID: 14630569
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J, Keliner K, Zilkens T, Schmidt-Gayk H, Selisko T, Scholz GH.
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [Abstract] [Full Text] [Related]

  • 13. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC, Dunger DB.
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC, Dunger DB.
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [Abstract] [Full Text] [Related]

  • 15. Experimental diabetes mellitus in a teleost fish. II. Roles of insulin, growth hormone (GH), insulin-like growth factor-I, and hepatic GH receptors in diabetic growth inhibition in the goby, Gillichthys mirabilis.
    Kelley KM, Gray ES, Siharath K, Nicoll CS, Bern HA.
    Endocrinology; 1993 Jun; 132(6):2696-702. PubMed ID: 8504769
    [Abstract] [Full Text] [Related]

  • 16. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J, Urban M, Urban B, Głowińska B, Florys B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Jun; 10(1):41-8. PubMed ID: 15355738
    [Abstract] [Full Text] [Related]

  • 17. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.
    Vasilatos-Younken R, Dunnington EA, Siegel PB, McMurtry JP.
    Gen Comp Endocrinol; 1997 Jan; 105(1):31-9. PubMed ID: 9000465
    [Abstract] [Full Text] [Related]

  • 18. Involvement of insulin-like growth factor-I in the control of glucose homeostasis.
    Clemmons DR.
    Curr Opin Pharmacol; 2006 Dec; 6(6):620-5. PubMed ID: 17030015
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone-insulin-like growth factor-I axis in adult insulin-dependent diabetic patients: evidence for central hypersensitivity to growth hormone-releasing hormone and peripheral resistance to growth hormone.
    Fainstein Day P, Fagin JA, Vaglio RM, Litwak LE, Picasso MF, Gutman RA.
    Horm Metab Res; 1998 Dec; 30(12):737-42. PubMed ID: 9930632
    [Abstract] [Full Text] [Related]

  • 20. Low plasma growth hormone binding protein in IDDM.
    Mercado M, Molitch ME, Baumann G.
    Diabetes; 1992 May; 41(5):605-9. PubMed ID: 1568530
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.